Evidence map›Paper›PMID 28993838›Full record

ReviewHandbook of experimental pharmacology2018

Delta Opioid Receptor Expression and Function in Primary Afferent Somatosensory Neurons.

Amaury François, Grégory Scherrer

Open access · greenAbstract readReview
In one paragraph

Review in Handbook of experimental pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. HDAC6 Inhibition Reverses Cisplatin-Induced Mechanical Hypersensitivity via Tonic Delta Opioid Receptor Signaling.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2022
    Article
  8. Article
  9. Peripherally Acting Opioids in Orofacial Pain.Frontiers in neuroscience · 2021
    Review
  10. Article
  11. Immortalized Dorsal Root Ganglion Neuron Cell Lines.Frontiers in cellular neuroscience · 2020
    Review
  12. The Delta-Opioid Receptor; a Target for the Treatment of Pain.Frontiers in molecular neuroscience · 2020
    Review
  13. Endogenous and Exogenous Opioids in Pain.Annual review of neuroscience · 2018
    Review
  14. Article
  15. Inhibitory GMolecular pain
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Amaury FrançoisDepartment of Anesthesiology, Perioperative and Pain Medicine, Stanford Neurosciences Institute, Stanford University School of Medicine, Palo Alto, CA, USA.
Grégory ScherrerDepartment of Anesthesiology, Perioperative and Pain Medicine, Stanford Neurosciences Institute, Stanford University School of Medicine, Palo Alto, CA, USA. gs25@stanford.edu.
Stanford University · US

Funding

Identification of cells and signaling mechanisms underlying opioid analgesia and side effectsR01DA044481 · NIDA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SCHERRER, GREGORY · 2017 to 2021
$1.8M
Analgesic Mechanism of Action of Endogenous Opioid Peptides Enkephalins with a FoR00DA031777 · NIDA · STANFORD UNIVERSITY · PI SCHERRER, GREGORY · 2012 to 2014
$737k
Analgesic Mechanism of Action of Endogenous Opioid Peptides Enkephalins with a FoK99DA031777 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SCHERRER, GREGORY · 2011 to 2011
$161k
NIDA NIH HHS K99 DA031777NIDA NIH HHS R00 DA031777NIDA NIH HHS R01 DA044481
6 · The paper itself

Abstract

The functional diversity of primary afferent neurons of the dorsal root ganglia (DRG) generates a variety of qualitatively and quantitatively distinct somatosensory experiences, from shooting pain to pleasant touch. In recent years, the identification of dozens of genetic markers specifically expressed by subpopulations of DRG neurons has dramatically improved our understanding of this diversity and provided the tools to manipulate their activity and uncover their molecular identity and function. Opioid receptors have long been known to be expressed by discrete populations of DRG neurons, in which they regulate cell excitability and neurotransmitter release. We review recent insights into the identity of the DRG neurons that express the delta opioid receptor (DOR) and the ion channel mechanisms that DOR engages in these cells to regulate sensory input. We highlight recent findings derived from DORGFP reporter mice and from in situ hybridization and RNA sequencing studies in wild-type mice that revealed DOR presence in cutaneous mechanosensory afferents eliciting touch and implicated in tactile allodynia. Mechanistically, we describe how DOR modulates opening of voltage-gated calcium channels (VGCCs) to control glutamatergic neurotransmission between somatosensory neurons and postsynaptic neurons in the spinal cord dorsal horn. We additionally discuss other potential signaling mechanisms, including those involving potassium channels, which DOR may engage to fine tune somatosensation. We conclude by discussing how this knowledge may explain the analgesic properties of DOR agonists against mechanical pain and uncovers an unanticipated specialized function for DOR in cutaneous mechanosensation.

Indexed as

AnimalsGanglia, SpinalHumansNeurons, AfferentPainReceptors, Opioid, deltaSensory Receptor CellsReceptors, Opioid, deltaDelta opioid receptorExcitabilityIon channelsMechanosensationNeuroanatomyNeurotransmitter releasePainPrimary afferent dorsal root ganglion neuronsTouch

Identifiers

PMID28993838
PMCPMC7348656
OpenAlexW2764288768

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.